Get started
Author

Savaş Gökçek

Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2025 · Yasin Sezgin, Oğur Karhan, et al. · Scientific Reports · 9
PDF
The prognostic role of systemic immune-inflammation index, SII, in Metastatic Castration-Resistant Prostate Cancer patients
2025 · Mehmet Uzun, Savas Gokcek, et al. · Discover Oncology · 6
Prognostic Role of Pan Immune Inflammation Value and Systemic Inflammation Response Index in Small Cell Lung Cancer
2023 · Mehmet Uzun, Eda Çalışkan Yıldırım, et al. · Acta Oncologica Turcica · 6
PDF
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study
2025 · Ogur Karhan, Serdar İleri, et al. · Therapeutic Advances in Medical Oncology · 5
The Effect of HER2 Status on Gastric Cancer Survival and the Clinical Implications of the HER2-Low Definition: A Retrospective Study
2025 · Mehmet Uzun, Savas Gokcek, et al. · Medicina · 2
PDF
Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG)
2026 · Bengü Dursun, Şendağ Yaslıkaya, et al. · Cancers · 1
PDF
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)
2025 · Ali Kalem, Tulay Kus, et al. · Journal of Clinical Medicine · 1
PDF
The Prognostic Role of SIRI and PIV in Patients with Metastatic Non-Small Cell Lung Cancer Receiving Systemic Chemotherapy
2024 · Mehmet Uzun, Buket Hamitoglu, et al. · Research Square · 1
Nadir Tümörler
2022 · Ali Murat Sedef, Gülçin Şahingöz Erdal, et al. · Akademisyen Kitabevi eBooks · 1
Tumor Biology is More Strongly Associated with Pathological Complete Response Than Clinical Stage in Breast Cancer Treated with Neoadjuvant Systemic Therapy
2026 · Mehmet Uzun, Savaş Gökçek, et al. · Acta haematologica oncologica Turcica.
PDF
Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma: A Multicentre Cohort Study
2026 · Savaş Gökçek, Mehmet Uzun, et al. · Journal of Basic and Clinical Health Sciences
PDF
Comparison of 24 Versus 46-Hour 5-FU Infusion Durations in the Perioperative FLOT Therapy for Gastric Cancer
2026 · Savas Gokcek, Pervin Can Sancı, et al. · Medicina
Prognostic value of the lung immune prognostic index in metastatic gastric cancer: a single-center retrospective cohort study
2026 · Savas Gokcek, Busra Kanbur, et al. · Future Oncology
Evaluation of Web-based Information on Phytotherapy for Cancer Patients: A Quality and Readability Analysis
2026 · Mehmet Uzun, Savas Gokcek, et al. · Journal of Cancer Education
Integrative in silico transcriptomic and pharmacogenomic analysis of CD276 as a candidate prognostic biomarker and therapeutic target in bladder cancer
2026 · Faruk Recep Özalp, Halil İbrahim Ellez, et al. · Discover Oncology
Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2026 · Yasin Sezgin, Oğur Karhan, et al. · Scientific Reports
PDF
3P Clinical significance of achieving no evidence of disease in HER2-positive metastatic breast cancer: A multicenter study by Turkish Oncology Group (TOG)
2026 · B. Dursun, S. Yaslikaya, et al. · ESMO Open
PDF
The relationship between HbA1c and atherosclerotic risk: a clinical evaluation in a non-diabetic population
2026 · Savas Gokcek, Bülent Sözmen, et al. · IMC Journal of Medical Science
PDF
Ki-67 and Platelet-to-Lymphocyte Ratio (PLR) as Predictors of Progression-Free Survival in Metastatic Breast Cancer Receiving CDK4/6 Inhibitors: Clinical Implications
2026 · Savas Gokcek, Mehmet Uzun, et al. · Cancer Management and Research
PDF
Oligometastatik Meme Kanserinde Bireyselleştirilmiş Tedavi Stratejileri: Cerrahi Ne Kadar Gerekli?
2026 · Mehmet Uzun, Savaş Gökçek · Akademisyen Kitabevi eBooks
Meme Kanseri
2026 · Semra Taş, Ali Alper Solmaz, et al. · Akademisyen Kitabevi eBooks
PDF
Real World Outcomes of First Line Pertuzumab Based Therapy in HER2 Positive Metastatic Breast Cancer: Performance Status, Metastatic Burden and Nutritional Status as Prognostic Factors
2026 · Savaş Gökçek, Emine Bihter Eniseler, et al. · Eurasian Journal of Medical Investigation
İki tip luminal B meme kanseri: HER-2 negatif ve HER-2 pozitif metastatik luminal B meme kanseri arasındaki klinik farklılıklar
2025 · Mehmet Uzun, Savaş Gökçek, et al. · Adıyaman Üniversitesi Sağlık Bilimleri Dergisi
PDF
The Prognostic Role of Systemic Inflammatory Response Index in Surgically Treated Pancreatic Ductal Adenocarcinoma Patients
2025 · Eda Çalışkan Yıldırım, Savaş Gökçek, et al. · Journal of Basic and Clinical Health Sciences
PDF
FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG)
2025 · Ali Kalem, Tulay Kus, et al. · Cancers
PDF
Works count: 30
Citation count: 32
H-index: 4
I10-index:
Year
Topic
Type